Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Expanded Carrier Screening Market CAGR Outlook And Future Development
The expanded carrier screening market has seen swift growth in recent years. It is anticipated to expand from $2.46 billion in 2025 to $2.87 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. The historical increase can be attributed to a heightened awareness of inherited genetic disorders, the expansion of prenatal screening initiatives, improvements in genetic sequencing accuracy, a growing availability of diagnostic laboratories, and rising clinician adoption of carrier screening tools.
The expanded carrier screening market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $5.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This anticipated growth throughout the forecast period stems from several factors, including a heightened demand for customized reproductive health solutions, the growing incorporation of AI-based variant interpretation, the broadening of population-level screening programs, increasing capital allocated to genomic data platforms, and an elevated emphasis on proactive genetic healthcare. Key trends for this period encompass the broader uptake of pan-ethnic genetic screening panels, an escalating need for preconception carrier testing, the expanding application of next-generation sequencing technologies, the proliferation of direct-to-provider genetic testing options, and a stronger emphasis on integrating genetic counseling.
Get A Free Sample Report With In-Depth Market Insights:
Expanded Carrier Screening Market Demand Drivers Opening New Revenue Streams
The expanding occurrence of genetic diseases is anticipated to drive the progress of the expanded carrier screening market moving forward. Genetic diseases are conditions resulting from abnormalities or mutations within an individual’s DNA, which can be inherited or develop spontaneously. The growing prevalence of genetic diseases is due to advancements in diagnostic methods, especially next-generation sequencing and other genomic tools, which have considerably improved the capacity to detect and identify a broad spectrum of genetic disorders that were previously undiagnosed or incorrectly categorized. Expanded carrier screening aids in identifying carriers of genetic disorders before symptoms manifest, enabling informed reproductive choices and mitigating the risk of transmitting inherited conditions to subsequent generations. For example, in October 2024, data from the Cystic Fibrosis Trust, a UK-based charity dedicated to aiding individuals with cystic fibrosis, reported 11,148 cystic fibrosis patients registered in 2022, a number that rose to 11,318 in 2023, marking a 1.5% increase in patient registrations year-over-year. Consequently, the increasing prevalence of genetic diseases is stimulating the growth of the carrier screening market.
Expanded Carrier Screening Market Segment Landscape: Which Areas Lead Development?
The expanded carrier screening market covered in this report is segmented –
1) By Type: Customized Panel Testing, Predesigned Panel Testing
2) By Technology: Deoxyribonucleic Acid Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies
3) By Application: Preconception, Prenatal, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Laboratories, Specialty Clinics, Other End-Users
Subsegments:
1) By Customized Panel Testing: Single Gene Testing, Multi-Gene Panel Testing, Ethnicity-Based Custom Panels, Condition-Specific Custom Panels, Family History-Based Custom Panels
2) By Predesigned Panel Testing: Pan-Ethnic Panels, Universal Carrier Panels, Population-Specific Panels, Disorder-Focused Panels, Expanded Predefined Panels
Expanded Carrier Screening Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the expanded carrier screening market are concentrating on the creation of innovative solutions, such as extensive next-generation sequencing-based panels, to identify a broad spectrum of genetic conditions with enhanced accuracy and efficiency. These comprehensive next-generation sequencing (NGS)-based panels are sophisticated genetic tests that analyze numerous genes concurrently to pinpoint a wide range of inherited disorders with high precision and speed. For example, in February 2023, Fulgent Genetics Inc., a US-based genomic testing firm, unveiled the Beacon787 Expanded Carrier Screening Panel, specifically designed to assess 787 genes connected to severe inherited conditions. This panel offers extensive coverage for more than 700 autosomal recessive and X-linked disorders, including all Tier 3 genes. It harnesses advanced next-generation sequencing technology, providing high analytical accuracy, a pan-ethnic methodology, and a swift turnaround time of 2–3 weeks, thereby positioning it as one of the most comprehensive and precise reproductive carrier screening solutions currently available.
Expanded Carrier Screening Market Industry Leaders And Competitive Landscape
Major companies operating in the expanded carrier screening market are Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BGI Genomics Co. Ltd., Ambry Genetics Corporation, GeneDx Inc., BillionToOne Inc., MedGenome Labs Ltd., Centogene N.V., Baylor Miraca Genetics Laboratories LLC, Victorian Clinical Genetics Services, Pathkind Diagnostics Private Limited, Medicover Genetics GmbH, NxGen MDx LLC, GeneTech
View The Full Expanded Carrier Screening Market Report:
Expanded Carrier Screening Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the expanded carrier screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the expanded carrier screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
